Jane Wang

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Mohamed A. Adam · 4 shared papers, 2024–2026 · strength 0.83
   • Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
   • Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
   • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
2. Adnan A. Alseidi · 4 shared papers, 2024–2026 · strength 0.83
   • Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
   • Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
   • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
3. Amir Ashraf‐Ganjouei · 3 shared papers, 2024–2026 · strength 0.66
   • Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
   • Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
   • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
4. Eric K. Nakakura · 3 shared papers, 2024–2025 · strength 0.60
   • Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
   • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
   • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
5. Ajay V. Maker · 2 shared papers, 2024 · strength 0.36
   • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
   • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
6. Kimberly Saunders Kirkwood · 2 shared papers, 2024 · strength 0.36
   • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
   • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
7. Sophia Hernandez · 1 shared paper, 2025 · strength 0.24
   • Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
8. J. Ejie · 1 shared paper, 2025 · strength 0.24
   • Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
9. Timothy R. Donahue · 1 shared paper, 2026 · strength 0.24
   • Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
10. Neema Jamshidi · 1 shared paper, 2026 · strength 0.24
    • Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
11. Han Yin · 1 shared paper, 2024 · strength 0.18
    • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
12. June S. Peng · 1 shared paper, 2024 · strength 0.18
    • Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
13. Andrew H. Ko · 1 shared paper, 2024 · strength 0.18
    • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
14. Phoebe N. Miller · 1 shared paper, 2024 · strength 0.18
    • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
15. Sunhee S. Kim · 1 shared paper, 2024 · strength 0.18
    • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
16. Grace Kim · 1 shared paper, 2024 · strength 0.18
    • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗
17. Margaret A. Tempero · 1 shared paper, 2024 · strength 0.18
    • Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.